5I94

Crystal structure of human glutaminase C in complex with the inhibitor UPGL-00019


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.983 Å
  • R-Value Free: 0.231 
  • R-Value Work: 0.173 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Design and evaluation of novel glutaminase inhibitors.

McDermott, L.A.Iyer, P.Vernetti, L.Rimer, S.Sun, J.Boby, M.Yang, T.Fioravanti, M.O'Neill, J.Wang, L.Drakes, D.Katt, W.Huang, Q.Cerione, R.

(2016) Bioorg.Med.Chem. 24: 1819-1839

  • DOI: 10.1016/j.bmc.2016.03.009
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • A novel set of GAC (kidney glutaminase isoform C) inhibitors able to inhibit the enzymatic activity of GAC and the growth of the triple negative MDA-MB-231 breast cancer cells with low nanomolar potency is described. Compounds in this series have a r ...

    A novel set of GAC (kidney glutaminase isoform C) inhibitors able to inhibit the enzymatic activity of GAC and the growth of the triple negative MDA-MB-231 breast cancer cells with low nanomolar potency is described. Compounds in this series have a reduced number of rotatable bonds, improved ClogPs, microsomal stability and ligand efficiency when compared to the leading GAC inhibitors BPTES and CB-839. Property improvements were achieved by the replacement of the flexible n-diethylthio or the n-butyl moiety present in the leading inhibitors by heteroatom substituted heterocycloalkanes.


    Organizational Affiliation

    University of Pittsburgh, Department of Pharmaceutical Sciences, Pittsburgh, PA 15261, USA; University of Pittsburgh, Drug Discovery Institute, Pittsburgh, PA 15261, USA. Electronic address: lam179@pitt.edu.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Glutaminase kidney isoform, mitochondrial
A, B, C, D
539Homo sapiensMutation(s): 0 
Gene Names: GLS (GLS1, KIAA0838)
EC: 3.5.1.2
Find proteins for O94925 (Homo sapiens)
Go to Gene View: GLS
Go to UniProtKB:  O94925
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
69V
Query on 69V

Download SDF File 
Download CCD File 
A, B
2-phenyl-N-{5-[4-({5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}oxy)piperidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide
C25 H25 N7 O3 S2
BAGWZESOKRULGY-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
69VIC50: 30 nM (99) BINDINGDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.983 Å
  • R-Value Free: 0.231 
  • R-Value Work: 0.173 
  • Space Group: P 1 21 1
Unit Cell:
Length (Å)Angle (°)
a = 49.440α = 90.00
b = 137.790β = 94.68
c = 175.755γ = 90.00
Software Package:
Software NamePurpose
PHENIXphasing
PHENIXrefinement
HKL-2000data scaling
HKL-2000data reduction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History & Funding Information

Deposition Data

  • Deposited Date: 2016-02-19 
  • Released Date: 2016-05-11 
  • Deposition Author(s): Huang, Q., Cerione, R.

Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical SciencesUnited StatesGM040654
National Institutes of Health/National Institute of General Medical SciencesUnited StatesGM047458

Revision History 

  • Version 1.0: 2016-05-11
    Type: Initial release
  • Version 1.1: 2017-09-20
    Type: Advisory, Author supporting evidence, Database references, Derived calculations